Clinical Trials Logo

Clinical Trial Summary

FOCUS is the first prospective randomized study comparing standard of care (mycophenolate mofetil) to adalimumab in recently active non infectious uveitis (NIU) with steroid dependency. There is no firm evidence or randomized trials that compared classical immunosuppressive compounds to biological agents; or identified the best treatment in this condition. The burden of NIU has been reduced with the use of immunosuppressive agents and biologics, raising the question of which of these compounds should be preferentially used in recently active NIU with steroid dependency.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06258915
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact Bahram BODAGHI, Pr
Phone +33142163728
Email bahram.bodaghi@aphp.fr
Status Not yet recruiting
Phase Phase 3
Start date March 1, 2024
Completion date November 1, 2027

See also
  Status Clinical Trial Phase
Terminated NCT03711929 - LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye Phase 3